Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
Lappin
Graham
G
Xceleron Ltd, The Biocentre, Innovation Way, York YO10 5NY, UK. graham.lappin@xceleron.com <graham.lappin@xceleron.com>
Shishikura
Yoko
Y
Jochemsen
Roeline
R
Weaver
Richard John
RJ
Gesson
Charlotte
C
Houston
Brian
B
Oosterhuis
Berend
B
Bjerrum
Ole J
OJ
Rowland
Malcolm
M
Garner
Colin
C
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001682:Biological Availability; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D016593:Terfenadine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D055815:Young Adult
D018926:Anti-Allergic Agents; D016593:Terfenadine; C093230:fexofenadine